36 Scopus citations


Nicotinamide adenine dinucleotide (NAD +) biosynthesis and its regulation have recently been attracting markedly increasing interest. Aging is marked by a systemic decrease in NAD + across multiple tissues. The dysfunction of NAD + biosynthesis plays a critical role in the pathophysiologies of multiple diseases, including age-associated metabolic disorders, neurodegenerative diseases, and mental disorders. As downstream effectors, NAD +-dependent enzymes, such as sirtuins, are involved in the progression of such disorders. These recent studies implicate NAD + biosynthesis as a potential target for preventing and treating age-associated diseases. Indeed, new studies have demonstrated the therapeutic potential of supplementing NAD + intermediates, such as nicotinamide mononucleotide and nicotinamide riboside, providing a proof of concept for the development of an effective anti-aging intervention.

Original languageEnglish
Article number132
StatePublished - Jan 1 2018


  • Biosynthesis Aging
  • NAD+

Fingerprint Dive into the research topics of 'NAD<sup>+</sup> biosynthesis, aging, and disease'. Together they form a unique fingerprint.

  • Cite this